We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOD
276
Gladstone Commercial Corp
GOOD
$630M
$266K 0.02%
12,535
– –
PSA icon
277
Public Storage
PSA
$60.4B
$259K 0.02%
1,091
– –
GSK icon
278
GSK
GSK
$101B
$254K 0.02%
5,078
+81
+2% +$4.06K
BSX icon
279
Boston Scientific
BSX
$74.5B
$251K 0.02%
5,826
+800
+16% +$30.8K
TU icon
280
Telus
TU
$15B
$251K 0.02%
13,600
-1,000
-7% -$18.5K
DES icon
281
WisdomTree US SmallCap Dividend Fund
DES
$2.22B
$249K 0.02%
9,173
-120
-1% -$3.28K
FISV
282
Fiserv Inc
FISV
$27.4B
$249K 0.02%
2,733
+609
+29% +$53.4K
MAR icon
283
Marriott International
MAR
$92.5B
$244K 0.02%
1,737
-180
-9% -$23.9K
AIVL icon
284
WisdomTree US AI Enhanced Value Fund
AIVL
$436M
$239K 0.02%
2,785
– –
IWN icon
285
iShares Russell 2000 Value ETF
IWN
$14.6B
$237K 0.02%
1,972
+184
+10% +$22.2K
SRE icon
286
Sempra
SRE
$56.2B
$234K 0.02%
3,410
– –
MTD icon
287
Mettler-Toledo International
MTD
$28.8B
$233K 0.02%
277
– –
BP icon
288
BP
BP
$111B
$232K 0.02%
5,676
-305
-5% -$12.8K
BXP icon
289
Boston Properties
BXP
$10.8B
$232K 0.02%
1,800
– –
MCO icon
290
Moody's
MCO
$82.8B
$232K 0.02%
1,190
-44
-4% -$8.35K
CDK
291
DELISTED
CDK Global, Inc.
CDK
$228K 0.02%
4,610
-22
-0.5% -$1.18K
L icon
292
Loews
L
$23.1B
$224K 0.02%
4,098
– –
IWM icon
293
iShares Russell 2000 ETF
IWM
$82.2B
$223K 0.02%
1,436
– –
LDOS icon
294
Leidos
LDOS
$17.6B
$223K 0.02%
2,794
+160
+6% +$11.7K
GS icon
295
Goldman Sachs
GS
$302B
$221K 0.02%
1,083
– –
MET icon
296
MetLife
MET
$61.4B
$221K 0.02%
4,453
– –
STT icon
297
State Street
STT
$52.2B
$221K 0.02%
3,938
-234
-6% -$14.5K
DSI icon
298
iShares MSCI KLD 400 Social ETF
DSI
$5.54B
$218K 0.02%
3,994
+116
+3% +$6.23K
KRC icon
299
Kilroy Realty
KRC
$4.22B
$214K 0.02%
2,900
– –
TREX icon
300
Trex
TREX
$5.05B
$208K 0.02%
5,812
– –
10 11
12
13 14

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.